Markham Richard J
Insider CIK 1362743 · NRX Director, 10% owner · CLCD Director, 10% owner · AVIR Director, 10% owner · ACUR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VXRT Vaxart, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 9,000 | — | $0 | 9,000 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 12,700 | — | $0 | 12,700 | SEC↗ |
| AVIR Vaxart, Inc. | A Award | 2018-02-13 | 2018-02-15 | 30,793,670 | — | $0 | 30,793,670 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-12 | 20,050 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-12 | 1,199,841 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-12 | 320,295 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-12 | 5,353 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion | 2015-05-11 | 2015-05-12 | 1,520,136 | — | $0 | 1,520,136 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion | 2015-05-11 | 2015-05-12 | 25,403 | — | $0 | 25,403 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | A Award deriv | 2015-05-05 | 2015-05-07 | 5,954 | — | $0 | 5,954 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2015-04-30 | 2015-05-04 | 6,870 | — | $0 | 6,870 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | P Buy deriv | 2015-01-12 | 2015-05-07 | 320,295 | — | $0 | 320,295 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | P Buy deriv | 2015-01-12 | 2015-05-07 | 16,041 | — | $0 | 16,041 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | P Buy deriv | 2015-01-12 | 2015-05-07 | 5,353 | — | $0 | 5,353 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | P Buy deriv | 2015-01-12 | 2015-05-07 | 959,872 | — | $0 | 959,872 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2014-05-15 | 2014-05-16 | 3,076 | — | $0 | 3,076 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 5,785,962 | — | $0 | 5,785,962 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 0 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 13,964,398 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 5,785,962 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion | 2014-02-14 | 2014-02-19 | 890,140 | — | $0 | 3,038,505 | SEC↗ |
| NRX NephroGenex, Inc. | A Award | 2014-02-14 | 2014-02-19 | 412,592 | — | $0 | 3,451,097 | SEC↗ |
| NRX NephroGenex, Inc. | P Buy | 2014-02-14 | 2014-02-19 | 790,000 | $12.00 | $9.48M | 4,241,097 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion | 2014-02-14 | 2014-02-19 | 2,148,365 | — | $0 | 2,148,365 | SEC↗ |
| ACUR ACURA PHARMACEUTICALS, INC | A Award deriv | 2013-01-02 | 2013-01-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACUR ACURA PHARMACEUTICALS, INC | A Award deriv | 2012-01-03 | 2012-01-04 | 15,000 | — | $0 | 15,000 | SEC↗ |